ReviewDiabetologia2018
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.
Subodh Verma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
479 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewDiabetologia2018
Subodh Verma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.